13F
中

ELAN ELANCO ANIMAL HEALTH INC

2026Q1 · CUSIP 28414H103 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
511
Δ holders QoQ
+31
Breadth percentile
Top 9%
Whale holders
205
Δ whales
+11
Inst. holding value
$13.0B
New positions
98
Closed positions
67
Price momentum (1Q)
-19.8%
Put / Call
6/6

Breadth history (34 quarters)

2018Q4: Δ+15 · h=169 2019Q1: Δ+167 · h=336 2019Q2: Δ+24 · h=360 2019Q3: Δ+12 · h=372 2019Q4: Δ+22 · h=394 2020Q1: Δ-29 · h=365 2020Q2: Δ+1 · h=366 2020Q3: Δ-13 · h=353 2020Q4: Δ+81 · h=434 2021Q1: Δ+5 · h=439 2021Q2: Δ+30 · h=469 2021Q3: Δ-23 · h=446 2021Q4: Δ+29 · h=475 2022Q1: Δ-12 · h=463 2022Q2: Δ-31 · h=432 2022Q3: Δ-17 · h=415 2022Q4: Δ-12 · h=403 2023Q1: Δ-13 · h=390 2023Q2: Δ-41 · h=349 2023Q3: Δ-2 · h=347 2023Q4: Δ+4 · h=351 2024Q1: Δ+20 · h=371 2024Q2: Δ+29 · h=400 2024Q3: Δ-15 · h=385 2024Q4: Δ+7 · h=392 2025Q1: Δ-27 · h=365 2025Q2: Δ+0 · h=365 2025Q3: Δ+42 · h=407 2025Q4: Δ+73 · h=480 2026Q1: Δ+31 · h=511 2018Q4: holders=169 2019Q1: holders=336 2019Q2: holders=360 2019Q3: holders=372 2019Q4: holders=394 2020Q1: holders=365 2020Q2: holders=366 2020Q3: holders=353 2020Q4: holders=434 2021Q1: holders=439 2021Q2: holders=469 2021Q3: holders=446 2021Q4: holders=475 2022Q1: holders=463 2022Q2: holders=432 2022Q3: holders=415 2022Q4: holders=403 2023Q1: holders=390 2023Q2: holders=349 2023Q3: holders=347 2023Q4: holders=351 2024Q1: holders=371 2024Q2: holders=400 2024Q3: holders=385 2024Q4: holders=392 2025Q1: holders=365 2025Q2: holders=365 2025Q3: holders=407 2025Q4: holders=480 2026Q1: holders=511 -167 -83.5 +0 +83.5 +167 152345537 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 12 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 9% — —
2025Q4 Top 6% -19.8% —
2025Q3 Top 6% +17.6% -2.7%
2024Q2 Top 8% -3.1% -22.4%
2024Q1 Top 15% -13.8% -18.7%
2021Q4 Top 17% -9.8% -30.1%
2021Q2 Top 7% +4.8% -20.3%
2020Q4 Top 6% +15.2% +3.8%

Options Sentiment

Put holders
6
QoQ: -4
Call holders
6
QoQ: -3

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.49
EPS YoY
-165.3%
Revenue (TTM)
$4.9B
Revenue YoY
+10.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1.2B 2022-09-30: $1.0B 2022-12-31: $1.0B 2023-03-31: $1.3B 2023-06-30: $1.1B 2023-09-30: $1.1B 2023-12-31: $1.0B 2024-03-31: $1.2B 2024-06-30: $1.2B 2024-09-30: $1.0B 2024-12-31: $1.0B 2025-03-31: $1.2B 2025-06-30: $1.2B 2025-09-30: $1.1B 2025-12-31: $1.1B 2026-03-31: $1.4B 2022-06-30: EPS -0.02 2022-09-30: EPS -0.13 2022-12-31: EPS -0.11 2023-03-31: EPS 0.21 2023-06-30: EPS -0.20 2023-09-30: EPS -2.22 2023-12-31: EPS -0.29 2024-03-31: EPS 0.06 2024-06-30: EPS -0.10 2024-09-30: EPS 0.73 2024-12-31: EPS -0.01 2025-03-31: EPS 0.13 2025-06-30: EPS 0.02 2025-09-30: EPS -0.07 2025-12-31: EPS -0.55 2026-03-31: EPS 0.11 0B 0.7B 1.4B $B -2.44 -0.82 0.80 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 21 2024-09-30: PE 34.92024-12-31: PE 16.52025-03-31: PE 17.22025-06-30: PE 20.62025-09-30: PE 301.3 15 166 316 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)